Navigation Links
AlloSource Distributes Record Amount of Tissue in 2008

Non-profit tissue bank grows 21 percent helping patients in more donor communities

CENTENNIAL, Colo., Feb. 4 /PRNewswire/ -- AlloSource, one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures, finished 2008 distributing more life-saving and life-enhancing allografts into its donor communities than ever before, and was recognized with five business accolades.

AlloSource is a leading U.S. tissue network and is one of the largest biotech companies in Colorado employing more than 350 people. In 2008, AlloSource processed more than 4,100 tissue donors whose gifts helped thousands of people improve their mobility and functionality. AlloSource processed more than 3,200 skin donors whose generous gifts helped save the lives of burn victims around the country.

"2008 was a particularly significant year for AlloSource. We reached milestones in all business areas and the great work of our associates was recognized with five significant awards," said Thomas A. Cycyota, AlloSource President and Chief Executive Officer. "But most importantly, we are incredibly thankful to the 4,100 people (and their families) that chose to be tissue donors, whose gifts we processed into allografts that helped people to walk again, live free from pain, avoid limb amputation and survive devastating burns."

2008 accomplishments include:

  • Organic revenue growth of 21 percent as a result of the Company's enhanced methods for tissue recovery, processing and distribution.
  • Raising the bar for a more rigorous processing environment and quality control system by registering with the FDA as a Medical Device (21 CFR Part 820) Establishment.
  • Reinvesting close to 45 percent of revenues with Organ Procurement Organization recovery agencies. These funds were used for a host of donation awareness and education programs in communities such as Buffalo, Chicago, Denver, St. Louis and Des Moines, San Diego and Cincinnati.
  • Began manufacturing Osteocel, making AlloSource the only U.S. tissue network to produce and distribute the complete range of bone growth allograft products.
  • Recognition from five prestigious awards programs:
    • Healthcare Innovator of the Year (Denver Business Journal)
    • Best Companies to Work For in Colorado (Colorado Society for Human Resources Management) - Finalist for second consecutive year; 3rd place out of 15 companies selected
    • Large Company of the Year (City of Centennial, CO)
    • 2008 Top Company (ColoradoBiz Magazine) - Finalist
    • Samaritan Institute Award (Colorado Ethics In Business Alliance) - Finalist

"Coming off of such a successful year, we are energized to continue to pursue our mission in 2009 of honoring the gift of tissue donation by responsibly processing and distributing life-saving and life-enhancing human allograft tissue for our communities." added Cycyota.

About AlloSource

AlloSource delivers powerful possibilities to the medical community, patients and donor families. AlloSource is a non-profit company that offers more than 200 precise bone, skin, soft-tissue and custom-machined allografts for use in a host of life-saving and life-enhancing medical procedures. As the world's leader in fresh cartilage tissue used for joint repair and skin allografts to heal severe burns, AlloSource has become one of the largest and most respected tissue networks in the country. AlloSource delivers unparalleled expertise and responsive customer service to its growing network of surgeons, partners and the country's most reputable organ procurement organizations. AlloSource is accredited by the American Association of Tissue Banks (AATB). For more information, visit

SOURCE AlloSource
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. AlloSource, Tissue Recipient Join Stars of Life Affected by Organ and Tissue Donation Aboard Donate Life Float in 2009 Rose Parade(R)
2. ETEX Announces Supply Agreement with AlloSource
3. OmniComm Systems, Inc. Experiences Record Year End Results - $18 Million in Signed Contracts for the Year 2008
4. Tully-Wihr Company Selects Web-Based Allscripts Electronic Health Record for 100 Northern California Physicians
5. Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS
6. Favrille and, Inc. Obtain Shareholder Approval to Move Forward With Merger
7. The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance
8. Yongye Biotechnology Announces Record Third Quarter Results
9. Kendle Reports Record 3Q 08 Net Income and Total Business Authorizations
10. Womens Surgery Recorded for the First Time on 4K Digital Cinema is Presented at the AAGL Congress
11. Abaxis Reports Record Revenues and Operating Income for the Second Quarter of Fiscal 2009
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... InSphero AG, the leading supplier of ... has promoted Melanie Aregger to serve as Chief Operating Officer. , Having ... management team and was promoted to Head of InSphero Diagnostics in 2014. ...
(Date:11/24/2015)... 24, 2015 HemoShear Therapeutics, LLC, a ... for metabolic disorders, announced today the appointment of ... of Directors (BOD). Mr. Watkins is the former ... Sciences (HGS), and also served as the chairman ... Powers , Chairman and CEO of HemoShear Therapeutics. ...
(Date:11/24/2015)... YORK , Nov. 24, 2015 According to ... than in 2005. This is something that many doctors, scientists, ... time. One questions remains: with fewer PSA tests being done, ... ? Dr. David Samadi, "Despite the ... the disease remains the second leading cancer cause of death ...
(Date:11/23/2015)... ... November 23, 2015 , ... ... development of its Nexera UC Unified Chromatography system. The award from R&D magazine ... new products of the year in the analytical and testing category. R&D Magazine ...
Breaking Biology Technology:
(Date:11/10/2015)... , Nov. 10, 2015 ... behavioral biometrics that helps to identify and verify ... Signature is considered as the secure and accurate ... identification of a particular individual because each individual,s ... accurate results especially when dynamic signature of an ...
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... ARBOR, Mich. , Oct. 29, 2015 /PRNewswire/ ... Eurofins Genomics for U.S. distribution of its DNA ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq kit. ... to enable the preparation of NGS libraries for ... plasma for diagnostic and prognostic applications in cancer ...
Breaking Biology News(10 mins):